Literature DB >> 23599668

Current diagnosis and treatment of anxiety disorders.

Alexander Bystritsky, Sahib S Khalsa, Michael E Cameron, Jason Schiffman.   

Abstract

Anxiety disorders are the most prevalent mental health conditions. Although they are less visible than schizophrenia, depression, and bipolar disorder, they can be just as disabling. The diagnoses of anxiety disorders are being continuously revised. Both dimensional and structural diagnoses have been used in clinical treatment and research, and both methods have been proposed for the new classification in the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-5). However, each of these approaches has limitations. More recently, the emphasis in diagnosis has focused on neuroimaging and genetic research. This approach is based partly on the need for a more comprehensive understanding of how biology, stress, and genetics interact to shape the symptoms of anxiety. Anxiety disorders can be effectively treated with psychopharmacological and cognitive-behavioral interventions. These inter ventions have different symptom targets; thus, logical combinations of these strategies need to be further studied in order to improve future outcomes. New developments are forthcoming in the field of alternative strategies for managing anxiety and for treatment-resistant cases. Additional treatment enhancements should include the development of algorithms that can be easily used in primary care and with greater focus on managing functional impairment in patients with anxiety.

Entities:  

Year:  2013        PMID: 23599668      PMCID: PMC3628173     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  129 in total

Review 1.  Therapeutic potential of CRF receptor antagonists: a gut-brain perspective.

Authors:  S C Heinrichs; Y Taché
Journal:  Expert Opin Investig Drugs       Date:  2001-04       Impact factor: 6.206

Review 2.  Pregabalin: a new anxiolytic.

Authors:  Bianca A Lauria-Horner; Robert B Pohl
Journal:  Expert Opin Investig Drugs       Date:  2003-04       Impact factor: 6.206

Review 3.  Cannabinoids and anxiety.

Authors:  Fabrício A Moreira; Carsten T Wotjak
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 4.  Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder.

Authors:  Raymond A Lorenz; Cherry W Jackson; Marianne Saitz
Journal:  Pharmacotherapy       Date:  2010-09       Impact factor: 4.705

Review 5.  Glutamate receptors in extinction and extinction-based therapies for psychiatric illness.

Authors:  Karyn M Myers; William A Carlezon; Michael Davis
Journal:  Neuropsychopharmacology       Date:  2010-07-14       Impact factor: 7.853

6.  Endocrine, cognitive and hippocampal/cortical 5HT 1A/2A receptor changes evoked by a time-dependent sensitisation (TDS) stress model in rats.

Authors:  Brian H Harvey; Carla Naciti; Linda Brand; Dan J Stein
Journal:  Brain Res       Date:  2003-09-05       Impact factor: 3.252

7.  Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome.

Authors:  James F Leckman; David L Pauls; Heping Zhang; Maria C Rosario-Campos; Liliya Katsovich; Kenneth K Kidd; Andrew J Pakstis; John P Alsobrook; Mary M Robertson; William M McMahon; John T Walkup; Ben J M van de Wetering; Robert A King; Donald J Cohen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-01-01       Impact factor: 3.568

8.  Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.

Authors:  Jamie D Feusner; Lauren Kerwin; Sanjaya Saxena; Alexander Bystritsky
Journal:  Psychopharmacol Bull       Date:  2009

9.  Cognition-enhancing and anxiolytic effects of memantine.

Authors:  Rimante Minkeviciene; Pradeep Banerjee; Heikki Tanila
Journal:  Neuropharmacology       Date:  2008-02-29       Impact factor: 5.250

Review 10.  Neuroanatomical circuits modulating fear and anxiety behaviors.

Authors:  D S Charney
Journal:  Acta Psychiatr Scand Suppl       Date:  2003
View more
  31 in total

1.  Effects of N-acetylcysteine amide on anxiety and stress behavior in zebrafish.

Authors:  Carlos G Reis; Ricieri Mocelin; Radharani Benvenutti; Matheus Marcon; Adrieli Sachett; Ana P Herrmann; Elaine Elisabetsky; Angelo Piato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-11-25       Impact factor: 3.000

2.  Neuronal Deletion of Kmt2a/Mll1 Histone Methyltransferase in Ventral Striatum is Associated with Defective Spike-Timing-Dependent Striatal Synaptic Plasticity, Altered Response to Dopaminergic Drugs, and Increased Anxiety.

Authors:  Erica Y Shen; Yan Jiang; Behnam Javidfar; Bibi Kassim; Yong-Hwee E Loh; Qi Ma; Amanda C Mitchell; Venu Pothula; A Francis Stewart; Patricia Ernst; Wei-Dong Yao; Gilles Martin; Li Shen; Mira Jakovcevski; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2016-08-03       Impact factor: 7.853

3.  Anxiety and depression in Multiple Sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life.

Authors:  Mariam Hanna; Lauren Beth Strober
Journal:  Mult Scler Relat Disord       Date:  2020-06-06       Impact factor: 4.339

Review 4.  Anxiety and depression-Important psychological comorbidities of COPD.

Authors:  Marsus I Pumar; Curt R Gray; James R Walsh; Ian A Yang; Tricia A Rolls; Donna L Ward
Journal:  J Thorac Dis       Date:  2014-11       Impact factor: 2.895

Review 5.  Damocles' syndrome revisited: Update on the fear of cancer recurrence in the complex world of today's treatments and survivorship.

Authors:  Margaret Cupit-Link; Karen L Syrjala; Shahrukh K Hashmi
Journal:  Hematol Oncol Stem Cell Ther       Date:  2018-02-19

6.  Neuroanatomical associations of depression, anxiety and apathy neuropsychiatric symptoms in patients with Alzheimer's disease.

Authors:  Abd Elazeim Abdalla Mohamed Nour; Yun Jiao; Gao-Jun Teng
Journal:  Acta Neurol Belg       Date:  2020-04-21       Impact factor: 2.396

7.  Bidirectional influence of limbic GIRK channel activation on innate avoidance behavior.

Authors:  Baovi N Vo; Ezequiel Marron Fernandez de Velasco; Timothy R Rose; Hannah Oberle; Haichang Luo; Corey R Hopkins; Kevin Wickman
Journal:  J Neurosci       Date:  2021-05-24       Impact factor: 6.167

8.  A non-linear dynamical approach to belief revision in cognitive behavioral therapy.

Authors:  David Kronemyer; Alexander Bystritsky
Journal:  Front Comput Neurosci       Date:  2014-05-15       Impact factor: 2.380

9.  Synergistic application of cardiac sympathetic decentralization and comprehensive psychiatric treatment in the management of anxiety and electrical storm.

Authors:  Sahib S Khalsa; Leila Shahabi; Olujimi A Ajijola; Alexander Bystritsky; Bruce D Naliboff; Kalyanam Shivkumar
Journal:  Front Integr Neurosci       Date:  2014-01-02

10.  The crossroads of anxiety: distinct neurophysiological maps for different symptomatic groups.

Authors:  Montserrat Gerez; Enrique Suárez; Carlos Serrano; Lauro Castanedo; Armando Tello
Journal:  Neuropsychiatr Dis Treat       Date:  2016-01-18       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.